Investor RelationsCOVID-19
  1. Home
  2. Point-of-Care Testing
  3. COVID-19 Testing
  4. COVID-19 Tests
  5. CLINITEST® Rapid COVID-19 Antigen Test
COVID-19 Key Visual 16-9

CLINITEST® Rapid COVID-19 Antigen Test

The clinical accuracy you need for results you can trust

Looking for information about our self-test?
COVID-19 Use Case

Monitoring Variants of Concern

Omicron Update
Siemens Healthineers is committed to monitoring all current and emerging variants of concern (VOCs) by directly testing with clinical samples and using a computer-based inspection tool called in silico analysis. The Omicron variant (B.1.1.529) is recognized by the WHO, CDC, and ECDC as a VOC. Siemens Healthineers internal data demonstrate that the CLINITEST® Rapid COVID-19 Antigen (Self) Test detects SARS-CoV-2 virus/coronavirus infection of the Omicron variant and its major sub-variants, including BA.1, BA.2, BA.2.75, BA.3, BA.4, BA.4.6, BA.5, BF.7, and XE.

Scalable COVID-19 antigen testing in 15 minutes

The CLINITEST® Rapid COVID-19 Antigen Test provides fast and accurate results wherever you need them most. The test has been confirmed to detect all current Variants of Concern, including the Delta variant, and it is easy to administer using either the nasal or nasopharyngeal swab methods. Results are available in 15 minutes.  

Simple procedure, reliable results

The lateral flow CLINITEST Rapid COVID-19 Antigen Test, distributed by Siemens Healthineers, is easy to administer by any trained professional in virtually any setting, without special equipment. When used as part of a comprehensive strategy, the CLINITEST Rapid COVID-19 Antigen Test can help communities stay ahead of the spread of COVID-19, even in the face of emerging variants.

Rapid Testing, Reliable Results with variant edits
POC Nasal Nasophar Sensi Speci
CLINITEST Dropper

Download the IFU

Official instructions for use for the CLINITEST COVID-19 Rapid Antigen Test:

Accessible testing, where you need it most

The CLINITEST Rapid COVID-19 Antigen Test can be used to test symptomatic or asymptomatic patients in a wide variety of settings.

More information

The products/features mentioned here are not commercially available in all countries. Their future availability cannot be guaranteed. Distributed by Siemens Healthineers. The CLINITEST Rapid COVID-19 Antigen Test for professional use is not available for sale in the U.S.

In the U.S., the CLINITEST Rapid COVID-19 Self-Test has not been FDA-cleared or approved but has been authorized by the FDA under an Emergency Use Authorization. This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

CLINITEST and all associated marks are trademarks of Siemens Healthcare Diagnostics, Inc., or its affiliates. All other trademarks and brands are the property of their respective owners.